These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 6549406)
1. [Xenograft of human bronchial squamous cell carcinoma and its sensitivity to therapy]. Bak M; Sugár J Orv Hetil; 1984 Dec; 125(52):3161-4, 3167. PubMed ID: 6549406 [No Abstract] [Full Text] [Related]
2. [Assessment of individual sensitivity to chemotherapy of human pulmonary tumors transplanted to subrenal capsule of CBA mice]. Skotinkova OI; Sergeeva NS; Moroz IA; Sviridova IK; Pelevina II Eksp Onkol; 1990; 12(4):71-3. PubMed ID: 2379492 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin. Mattern J; Wayss K; Volm M In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516 [TBL] [Abstract][Full Text] [Related]
4. [Results of chemotherapy of inoperable, non-small-cell bronchial carcinomas]. Fischer M; Mitrou PS Internist (Berl); 1980 Feb; 21(2):95-107. PubMed ID: 6154667 [No Abstract] [Full Text] [Related]
5. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft. Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274 [TBL] [Abstract][Full Text] [Related]
6. [Results of drug sensitivity test of UFT, doxorubicin and cisplatin using human urogenital cancers transplanted subcutaneously into nude mice]. Murahashi I; Hosoya Y; Mukae K; Honda M; Takasaki E Gan To Kagaku Ryoho; 1988 Nov; 15(11):3059-65. PubMed ID: 3142366 [TBL] [Abstract][Full Text] [Related]
7. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
8. [Cytostatic polychemotherapy regimens. II. Bronchopulmonary neoplasms]. Bild E; Carasievici E Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):177-82. PubMed ID: 1963699 [No Abstract] [Full Text] [Related]
9. [Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas]. Goldberg H; Tsalik M; Bernstein Z; Haim N Harefuah; 1994 Oct; 127(7-8):217-21, 286. PubMed ID: 7813942 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
13. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer]. Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000 [TBL] [Abstract][Full Text] [Related]
14. Hexamethylmelamine-induced regression of human lung tumors growing in immune deprived mice. Mitchley BC; Clarke SA; Connors TA; Neville AM Cancer Res; 1975 Apr; 35(4):1099-102. PubMed ID: 1116144 [TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871 [No Abstract] [Full Text] [Related]
16. [Intratumoral chemotherapy in the treatment of regional widespread pulmonary cancer]. Zvarych IuM; Shevchenko AI Klin Khir; 2003 Sep; (9):32-3. PubMed ID: 14663908 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the effects on the composition of alveolar surfactant of 2 chemotherapeutic protocols for carcinoma of the lung: peptichemio and MACC]. Balbi B; Benatti U; Morelli A; Sacco O; Vassallo F; Rossi GA; Ravazzoni C Ann Ital Med Int; 1987; 2(1):22-30. PubMed ID: 3275275 [No Abstract] [Full Text] [Related]
18. Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma. Sekine I; Nokihara H; Horiike A; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N Br J Cancer; 2004 Mar; 90(6):1125-8. PubMed ID: 15026789 [TBL] [Abstract][Full Text] [Related]
19. cis-dichlorodiammineplatinum(II) chemotherapy in experimental murine myeloma MOPC 104E. Ghanta VK; Jones MT; Woodard DA; Durant JR; Hiramoto RN Cancer Res; 1977 Mar; 37(3):771-4. PubMed ID: 851480 [TBL] [Abstract][Full Text] [Related]